Welcome to our dedicated page for Altria Group SEC filings (Ticker: MO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Altria Group, Inc. filings document formal disclosures for a U.S. tobacco and nicotine-products operating company. Form 8-K reports cover quarterly and annual results, consolidated financial statements, internal control reporting, material governance changes and completed debt issuances. The filings identify registered securities including MO common stock and exchange-listed notes, and describe senior unsecured notes and guarantees by Philip Morris USA.
Proxy materials cover annual meeting voting matters, director elections, board practices, executive compensation and pay-versus-performance disclosures. The record also includes capital-structure and financial-reporting disclosures tied to Altria's operating subsidiaries, shareholder returns, tobacco and health litigation items, FDA-regulated smoke-free products and other matters affecting its regulated consumer-products business.
Altria Group, Inc. senior vice president Heather A. Newman reported equity compensation activity in common stock. On February 26, 2026, she acquired 11,822 shares at $0.00 per share as shares were delivered upon vesting of Performance Stock Units originally granted on February 27, 2023.
On the same date, 11,343 shares of common stock were disposed of at $69.70 per share to satisfy tax obligations on the vesting of Performance Stock Units and Restricted Stock Units. After these transactions, she directly holds 158,870 common shares, a total that includes 69,760 Restricted Stock Units, and indirectly holds 5,499 shares in the Altria Deferred Profit-Sharing Plan.
Altria Group, Inc. executive Charles N. Whitaker reported equity compensation activity in company stock. He acquired 9,711 shares of common stock at no cost upon the vesting of Performance Stock Units granted on February 27, 2023. To cover taxes on this vesting and related Restricted Stock Units, 8,932 shares were disposed of at a price of $69.70 per share, the closing price on February 25, 2026. Following these transactions, he directly held 208,777 shares of common stock, which total includes 60,552 Restricted Stock Units, and indirectly held 1,017 shares in the Altria Deferred Profit-Sharing Plan.
Altria Group, Inc. executive vice president and COO Jody L. Begley reported equity compensation activity in company common stock. Begley acquired 17,166 shares upon vesting of Performance Stock Units originally granted on February 27, 2023, and 17,439 shares were withheld at a share price of $69.70 to cover taxes on vested Performance Stock Units and Restricted Stock Units. After these transactions, Begley directly held 312,954 shares of common stock, which includes 103,903 Restricted Stock Units, and indirectly held 50,779 shares through the Altria Deferred Profit-Sharing Plan.
Altria Group reported that Vice President and Controller Katie F. Patterson acquired 1,432 shares of common stock on February 25, 2026 through a grant or award at no cash cost, under the company’s equity compensation plans. After this award, she directly holds 18,357 shares, including 12,875 restricted stock units, and there are 266 additional shares held indirectly by her spouse.
McCarter Robert A. III reported acquisition or exercise transactions in this Form 4 filing.
ALTRIA GROUP, INC. executive Robert A. McCarter III, EVP & General Counsel, received an equity award in the form of 22,448 shares of common stock, described as Restricted Stock Units granted under the company’s equity compensation plans. Following this grant, his total reported direct holdings increased to 122,362 common shares, which the disclosure notes includes 97,180 Restricted Stock Units. This filing reflects a non-cash compensation award rather than an open-market stock purchase.
Altria Group executive Jody L. Begley reported an equity award that increases his holdings in the company. On February 25, 2026, he acquired 22,448 shares of Altria common stock as a grant or award, at a stated price of $0.00 per share, under the company’s equity compensation plans.
After this grant, Begley directly owns 313,227 common shares, which the filing notes includes 129,631 restricted stock units. He also indirectly holds 50,779 shares through the Altria Deferred Profit-Sharing Plan. The filing reflects compensation-related share accumulation rather than an open-market purchase or sale.
Altria Group SVP Charles N. Whitaker reported an equity award of 13,534 shares of common stock on February 25, 2026, recorded as a grant or award acquisition at no cash cost. The award consists of Restricted Stock Units granted under Altria’s equity compensation plans.
After this transaction, Whitaker directly holds 207,998 shares of Altria common stock, which total includes 75,107 Restricted Stock Units, and indirectly holds 1,017 shares through the Altria Deferred Profit-Sharing Plan.
Altria Group senior vice president Heather A. Newman reported an equity award of 11,973 shares of common stock on February 25, 2026, received as a grant or award under the company’s equity compensation plans at no purchase price. After this acquisition, her directly held position increased to 158,391 shares, which the footnotes state includes 87,479 restricted stock units. She also reports 5,499 shares held indirectly through the Altria Deferred Profit-Sharing Plan.
Altria Group EVP & CFO Salvatore Mancuso reported an equity award of 25,376 shares of common stock on February 25, 2026, recorded as a grant or award acquisition at $0.0000 per share. The filing notes these are Restricted Stock Units granted under Altria’s equity compensation plans, bringing his directly held total to 280,494 shares, including 108,913 Restricted Stock Units. He also reports 5,751 shares held indirectly through the Altria Deferred Profit-Sharing Plan.
Altria Group, Inc. files its annual report describing a primarily U.S.-focused tobacco and nicotine business built around Marlboro cigarettes, Black & Mild cigars, Copenhagen and Skoal MST, on! oral pouches and NJOY e‑vapor products. Reportable segments are smokeable, oral tobacco and e‑vapor, with joint-venture Horizon targeting heated tobacco sticks.
The filing highlights declining cigarette and MST volumes, growth in cigars and heavy competitive pressure from innovative and illicit nicotine products, especially flavored disposable e‑vapor. Altria details ITC orders banning NJOY ACE imports and sales, related 2025 e‑vapor goodwill and intangible impairments, and the multi‑phase Optimize & Accelerate cost and modernization program.
Extensive risk factors cover regulation (including FDA reviews, flavor and nicotine limits), litigation exposure, taxation, supply-chain and human-capital challenges, cybersecurity, climate and ESG expectations, plus equity stakes in ABI and Cronos that can face currency swings, regulatory issues and potential impairments.